Slebos RJ - Search Results

1

K-ras oncogene activation in atypical alveolar hyperplasias of the human lung.

Westra WH, Baas IO, Hruban RH, Askin FB, Wilson K, Offerhaus GJ, Slebos RJ. Westra WH, et al. Among authors: slebos rj. Cancer Res. 1996 May 1;56(9):2224-8. Cancer Res. 1996. PMID: 8616876

2

The ras gene family in human non-small-cell lung cancer.

Slebos RJ, Rodenhuis S. Slebos RJ, et al. J Natl Cancer Inst Monogr. 1992;(13):23-9. J Natl Cancer Inst Monogr. 1992. PMID: 1327034

3

Clinical significance of ras oncogene activation in human lung cancer.

Rodenhuis S, Slebos RJ. Rodenhuis S, et al. Among authors: slebos rj. Cancer Res. 1992 May 1;52(9 Suppl):2665s-2669s. Cancer Res. 1992. PMID: 1562997 Review.

4

Allele-specific detection of K-ras oncogene expression in human non-small-cell lung carcinomas.

Slebos RJ, Habets GG, Evers SG, Mooi WJ, Rodenhuis S. Slebos RJ, et al. Int J Cancer. 1991 Apr 22;48(1):51-6. doi: 10.1002/ijc.2910480110. Int J Cancer. 1991. PMID: 1850383

5

Differential activation of ras genes by point mutation in human colon cancer with metastases to either lung or liver.

Oudejans JJ, Slebos RJ, Zoetmulder FA, Mooi WJ, Rodenhuis S. Oudejans JJ, et al. Among authors: slebos rj. Int J Cancer. 1991 Dec 2;49(6):875-9. doi: 10.1002/ijc.2910490613. Int J Cancer. 1991. PMID: 1959991

6

Relationship between K-ras oncogene activation and smoking in adenocarcinoma of the human lung.

Slebos RJ, Hruban RH, Dalesio O, Mooi WJ, Offerhaus GJ, Rodenhuis S. Slebos RJ, et al. J Natl Cancer Inst. 1991 Jul 17;83(14):1024-7. doi: 10.1093/jnci/83.14.1024. J Natl Cancer Inst. 1991. PMID: 2072410

7

Incidence and possible clinical significance of K-ras oncogene activation in adenocarcinoma of the human lung.

Rodenhuis S, Slebos RJ, Boot AJ, Evers SG, Mooi WJ, Wagenaar SS, van Bodegom PC, Bos JL. Rodenhuis S, et al. Among authors: slebos rj. Cancer Res. 1988 Oct 15;48(20):5738-41. Cancer Res. 1988. PMID: 3048648

8

K-ras oncogene activation in lung adenocarcinomas from former smokers. Evidence that K-ras mutations are an early and irreversible event in the development of adenocarcinoma of the lung.

Westra WH, Slebos RJ, Offerhaus GJ, Goodman SN, Evers SG, Kensler TW, Askin FB, Rodenhuis S, Hruban RH. Westra WH, et al. Among authors: slebos rj. Cancer. 1993 Jul 15;72(2):432-8. doi: 10.1002/1097-0142(19930715)72:2<432::aid-cncr2820720219>3.0.co;2-#. Cancer. 1993. PMID: 8319174

9

Loss of a p53-associated G1 checkpoint does not decrease cell survival following DNA damage.

Slichenmyer WJ, Nelson WG, Slebos RJ, Kastan MB. Slichenmyer WJ, et al. Among authors: slebos rj. Cancer Res. 1993 Sep 15;53(18):4164-8. Cancer Res. 1993. PMID: 8364909

10

Overexpression of the p53 tumor suppressor gene product in primary lung adenocarcinomas is associated with cigarette smoking.

Westra WH, Offerhaus GJ, Goodman SN, Slebos RJ, Polak M, Baas IO, Rodenhuis S, Hruban RH. Westra WH, et al. Among authors: slebos rj. Am J Surg Pathol. 1993 Mar;17(3):213-20. doi: 10.1097/00000478-199303000-00001. Am J Surg Pathol. 1993. PMID: 8434702

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

124 results

Search Page